Betamethasone Dipropionate Ointment, Augmented
Product Images NDC 59651-699

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 59651-699). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (15 g Tube Label)

Package Label.principal Display Panel (15 g Tube Label)
This text appears to be a description of a medication called Betamethasone Dipropionate Ointment, USP (Augmented). The ointment is for topical use only and should not be taken orally, in the eyes, or intravaginally. Each gram contains 0.643 mg of betamethasone dipropionate USP (equivalent to 0.5 mg of betamethasone). The ointment base includes propylene glycol, propylene glycol monopalmitostearate, white petrolatum, and white wax. The usual dosage involves applying a thin film of the ointment once or twice daily without occlusion. It is recommended to limit the usage to 50g per week. The medication should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The product is distributed by Aurobindo Pharma USA, Inc., and made in India.*
FDA Label Image

Package Label.principal Display Panel (15 g Tube Carton Label)

Package Label.principal Display Panel (15 g Tube Carton Label)
This description is for a Betamethasone Dipropionate Ointment, USP (Augmented) with a specified strength for topical use only. Each gram contains specific amounts of betamethasone dipropionate USP and betamethasone in an ointment base. The ointment should be applied to the affected area up to twice daily without occlusion. The treatment should be limited to 50g per week. Store between 20°C to 25°C. The product is distributed by Aurobindo Pharma USA.*
FDA Label Image

Str (Betamethasonestr)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.